SLC16A1 and hepatocellular carcinoma: Further survival analysis showed that a low level of both SLC16A1-AS1 and SLC16A1 was much more beneficial to OS of HCC patients, followed by a low level of either SLC16A1-AS1 or SLC16A1, while a high level of both SLC16A1-AS1 and SLC16A1 was unfavorable for prognosis (Fig. 9F).